PM&R Meeting Abstracts

Official abstracts site for the AAPM&R Annual Assembly and the PM&R Journal.

MENU 
  • Home
  • Meetings Archive
    • AAPM&R Annual Assembly 2022
    • AAPM&R Annual Assembly 2021
    • AAPM&R Annual Assembly 2020
    • AAPM&R Annual Assembly 2019
  • Resources
  • Advanced Search

Sarcopenia in Lung Cancer: Value of Pectoralis Muscle Measurement

Abhishek Swarup, MD (St. Elizabeth's Medical Center - Tufts University, Brighton, Massachusetts); Isabel Cristina M. Emmerick, Dr; John Varlotto, MD; Feiran Lou, MD; Jennifer Baima, MD

Meeting: AAPM&R Annual Assembly 2020

Categories: General Rehabilitation (2020)

Session Information

Session Title: Virtual Poster Hall

Session Time: None. Available on demand.

Disclosures: Abhishek Swarup, MD: No financial relationships or conflicts of interest

Objective: Sarcopenia as measured by cross-sectional area of the iliopsoas has been associated with adverse outcomes for lung cancer. We investigated if routine measurements of the pectoralis as part of work-up and surveillance demonstrated any changes in muscle mass over the treatment period.

Design: Retrospective Study Setting : Pre and Postoperative Chest Imaging in Lung Cancer Patients Participants : 44 patients who underwent curative surgical resection for lung cancer in a 1-year period

Interventions: Serial cross-sectional area measurement of the pectoralis and iliopsoas muscle on CT scan

Main Outcome Measures: Cross-sectional area of the pectoralis muscle at 6 and 12 months after surgical resection

Results: CT scans were available for analysis in 33 patients. The mean age was 66 years old and the mean body mass index (BMI) was 28.62 kg/m2. 20 patients (60.6%) were female. 25 patients (75.8%) had pathological stage 1 non-small cell lung cancer, and 32 out of 33 patients underwent lobectomies. 22 patients (66.7%) were Eastern Cooperative Oncology Group (ECOG) performance status grade 0 at diagnosis. The mean iliopsoas area at diagnosis was 7.5 cm2. The mean pectoralis area at diagnosis was 13.8cm2, and 13.3 cm2 at 6 months post surgical resection. Area decreased to 12.4 cm2 at 12 months post resection. The decrease was statistically significant at 12 months. (p < 0.01) The number (percentage) of patients who exhibited decreases in mean pectoralis area was 22 patients (66.7 %) and 21 patients (63.6 %) at 6 and 12 months post resection, respectively. At 6 months, BMI, ECOG, and gender correlated with postoperative decrease, although these factors did not reach statistical significance (p < 0.1). Conclusions: Over half of the subjects lost pectoralis muscle mass in the first year. Assessment of sarcopenia provides crucial information when designing an exercise program for cancer patients.

Level of Evidence: Level III

To cite this abstract in AMA style:

Swarup A, Emmerick ICM, Varlotto J, Lou F, Baima J. Sarcopenia in Lung Cancer: Value of Pectoralis Muscle Measurement [abstract]. PM R. 2020; 12(S1)(suppl 1). https://pmrjabstracts.org/abstract/sarcopenia-in-lung-cancer-value-of-pectoralis-muscle-measurement/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to AAPM&R Annual Assembly 2020

PM&R Meeting Abstracts - https://pmrjabstracts.org/abstract/sarcopenia-in-lung-cancer-value-of-pectoralis-muscle-measurement/

Leading the Way. Baltimore, MD & Virtual. October 20-23, 2022. #aapmr22

PM&R Journal

View issues of PM&R on the Wiley Online Library »

American Academy of Physical Medicine and Rehabilitation

Visit the official site for the American Academy of Physical Medicine and Rehabilitation »

AAPM&R Annual Assembly

Visit the official site for the AAPM&R Annual Assembly »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Wiley